Third edition - WHO
2. Microbiological risk assessment 7 Specimens for which there is limited information 8 Risk assessment and genetically modified microorganisms 8 3. Basic laboratories – Biosafety Levels 1 and 2 9 Code of practice 9 Laboratory design and facilities 12 Laboratory equipment 14 Health and medical surveillance 16 Training 16 Waste handling 17
Download Third edition - WHO
Information
Domain:
Source:
Link to this page:
Documents from same domain
INVESTING IN HEALTH FOR ECONOMIC …
www.who.int2 INVESTING IN HEALTH FOR ECONOMIC DEVELOPMENT Report by the Mexican Commission on Macroeconomics and health 3 The …
WHO GOOD PRACTICES FOR PHARMACEUTICAL …
www.who.intworking document qas/09.297/rev.2 page 2 schedule for the proposed adoption process of document qas/09.297/rev.2: who good practices for pharmaceutical microbiology laboratories
NORMES ET STANDARDS EN INFRASTRUCTURES …
www.who.intnormes et standards en infrastructures et equipements du centre de sante et de promotion sociale, du centre medical avec antenne chirurgicale et du …
Heterotrophic Plate Count Measurement in …
www.who.intWorld Health Organization Sustainable Development and Healthy Environments Heterotrophic Plate Count Measurement in Drinking Water Safety Management
Annex 3 WHO good manufacturing practices for ...
www.who.int96 Introduction The fi rst WHO draft text on good manufacturing practices (GMP) was prepared in 1967 by a group of consultants at the request of the Twentieth
Annex 5 WHO good distribution practices for …
www.who.int236 1. Introduction Distribution is an important activity in the integrated supply-chain management of pharmaceutical products. Various people and entities are
Annex 2 WHO good practices for pharmaceutical …
www.who.int71 Introduction and scope of document Pharmaceutical microbiology laboratories may be involved in: — sterility testing; — detection, isolation, enumeration and identifi cation of microorganisms
LABORATORY BIOSAFETY MANUAL - WHO
www.who.intinterim guidelines WHO/CDS/CSR/LYO/2003.4 LABORATORY BIOSAFETY MANUAL SECOND EDITION (REVISED) WORLD HEALTH ORGANIZATION Geneva 2003
Mycobacteriology Laboratory Manual - WHO
www.who.intMycobacteriology Laboratory Manual ii Edita Pimkina, Infectious Diseases and Tuberculosis Hospital Affi liate of Public institution …
Laboratory Guidelines for enumerating CD4 T …
www.who.intSEA-HLM-392 Distribution: Limited Laboratory Guidelines for enumerating CD4 T Lymphocytes in the context of HIV/AIDS Regional Office for South-East Asia
Related documents
Regulatory Basics for Facility Design (WHO GMP): Biosafety ...
www.dcvmn.orgthe risk of release to the environment, not because of pathogentic aspects On the other hand, if e.g. the risk of reverse mutation exists for attenuated virus strains, a BSL 1 production facility may need additional biosafety features normally not required for BSL 1 …
Laboratory biosecurity guidance - WHO
www.who.intBiorisk management • Laboratory biosecurity guidance • September 2006 ii Abbreviations BSL3 Containment laboratory – Biosafety Level 3 BSL4 Maximum containment laboratory – Biosafety Level 4 FAO Food and Agriculture Organization of the United Nations GMO Genetically modified organism LBM3 Laboratory biosafety manual, third edition, 2004 LBG Biorisk …
Laboratory Biosafety and Biosecurity Risk Assessment ...
www.aam.org.arA biosafety risk assessment allows a laboratory to determine the relative level of risks its different activities pose and helps guide risk mitigation decisions so they are targeted to the most important risk. A biosafety risk assessment should consider every activity and procedure in a laboratory that involves infectious disease agents.
Laboratory Risk Assessment Tool - Stanford University
ehs.stanford.eduFeb 06, 2021 · The Stanford Laboratory Risk Assessment Tool provides a framework for risk . assessment that maps onto the scientific method, melding with the process . researchers already use to answer scientific questions. This tool allows researchers to systematically identify and control . hazards to reduce risk of injuries and incidents. Conduct a risk ...
Biosafety in Microbiological and Biomedical Laboratories ...
www.cdc.govin biomedical and clinical laboratories from a biosafety perspective. The BMBL is not intended to be a regulatory document although we recognize that some may use it in that way. The core principle of this document is protocol-driven risk assessment; it is not possible for a single document to identify all of the possible
Health and Safety Executive Management and operation of ...
www.hse.gov.ukThe Approved List is relevant to risk assessment for work with biological agents and the application of appropriate control measures. A risk assessment under COSHH regulation 6(2)(k), of work likely to expose any employees to biological agents, should consider the approved classification of any biological agent.